Skip to main content
TipRanks
Go Ultimate75% OFF

VISEN Pharmaceuticals (2561) Financial Statements

0 Followers

VISEN Pharmaceuticals Financial Overview

VISEN Pharmaceuticals's market cap is currently ¥1.43B. The company's EPS TTM is ¥-2.20; its P/E ratio is -4.85; VISEN Pharmaceuticals has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 160.73K¥ 2.78M¥ -1.67M¥ 0.00¥ 0.00
Gross Profit¥ 18.51K¥ 2.78M¥ -1.67M¥ -2.30M¥ -5.66M
Operating Income¥ -233.59M¥ -174.18M¥ -138.83M¥ -358.29M¥ -449.92M
EBITDA¥ -236.66M¥ -177.62M¥ -242.26M¥ -280.95M¥ -444.27M
Net Income¥ -246.86M¥ -182.24M¥ -249.57M¥ -288.97M¥ -486.18M
Balance Sheet
Cash & Short-Term Investments¥ 632.92M¥ 203.59M¥ 347.78M¥ 626.46M¥ 881.06M
Total Assets¥ 977.72M¥ 293.82M¥ 443.80M¥ 741.27M¥ 928.71M
Total Debt¥ 177.06M¥ 2.36M¥ 3.65M¥ 6.00M¥ 11.14M
Net Debt¥ -455.85M¥ -201.23M¥ -344.13M¥ -620.46M¥ -869.92M
Total Liabilities¥ 215.34M¥ 52.55M¥ 52.92M¥ 88.67M¥ 82.24M
Stockholders' Equity¥ 762.38M¥ 241.28M¥ 390.88M¥ 652.61M¥ 846.47M
Cash Flow
Free Cash Flow¥ -450.16M¥ -140.97M¥ -271.83M¥ -248.31M¥ -238.54M
Operating Cash Flow¥ -447.58M¥ -140.86M¥ -271.31M¥ -246.55M¥ -227.13M
Investing Cash Flow¥ 6.67M¥ -117.00K¥ -520.00K¥ -1.77M¥ -13.62M
Financing Cash Flow¥ 870.00M¥ -3.09M¥ -6.95M¥ -7.95M¥ 967.59M

Currency in CNY

VISEN Pharmaceuticals Earnings and Revenue History

-600M-300M0300M-200000 %-100000 %0 %100000 %EarningsProfit Margin202020212022202320242025RevenueEarningsProfit Margin

VISEN Pharmaceuticals Liabilities to Assets

0400M800M1.2B6 %12 %18 %24 %LiabilitiesLiabilities to Assets202020212022202320242025AssetsLiabilitiesLiabilities to Assets

VISEN Pharmaceuticals Cash Flow

-750M-500M-250M0250M500M750M1B1.3B202020212022202320242025OperatingInvestingFinancing

VISEN Pharmaceuticals Forecast EPS vs Actual EPS

-1.5-1.2-1-0.7-0.5Q4 24Q2 25Q4 25Q2 26Q4 26EPS EstimateBeatMiss